Anke Post

Dr. Post joined AC Immune in September 2024 as Chief Medical Officer. She brings with her extensive experience in leading neuroscience drug development programs in the pharmaceutical industry. She started her career at Novartis in Basel, and subsequently moved to Eli Lilly & Co., where she was responsible for a global medical group in early clinical development, located initially in the USA, and then in the United Kingdom. Then she became Head of Translational Medicine in Neurology at Roche in Basel. Following this extensive experience in both early and late-stage development in psychiatry and neurology-related indications, she moved into Biotech and Medtech companies from 2020 onwards. Here she held senior management and CMO responsibilities.   Anke studied medicine at Universities in Berlin, Vienna and Muenster, earning her M.D. from the University in Muenster, Germany. She completed her residency and fellowship training in Psychiatry, Psychotherapy and Neurology at the Max Planck Institute of Psychiatry in Munich where she obtained her specialization degree in 2002. Her habilitation degree was awarded by the Ludwig Maximilian University in Munich in 2004.